Advertisement
Screener

HI TECH PHARMACAL CO INC Research and Development Expense

HI TECH PHARMACAL CO INC Research and Development Expense

HI TECH PHARMACAL CO INC reported Research and Development Expense of $4.45 million for the 3-month period ending 2014-01-31, per its 10-Q filed 2014-03-11.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2014-03-11

  • HI TECH PHARMACAL CO INC research and development expense for the quarter ending 2014-01-31 was $4.45M, a 25.40% decline year-over-year.
  • HI TECH PHARMACAL CO INC research and development expense for the quarter ending 2013-10-31 was $5.09M, a 52.29% increase year-over-year.
  • HI TECH PHARMACAL CO INC research and development expense for the quarter ending 2013-07-31 was $3.96M, a 11.47% decline year-over-year.
  • HI TECH PHARMACAL CO INC research and development expense for the quarter ending 2013-04-30 was $3.55M, a 5.34% increase year-over-year.
  • HI TECH PHARMACAL CO INC research and development expense for fiscal 2013 was $17.33M, a 41.41% increase from fiscal 2012.
  • HI TECH PHARMACAL CO INC research and development expense for fiscal 2012 was $12.26M, a 31.08% increase from fiscal 2011.
  • HI TECH PHARMACAL CO INC research and development expense for fiscal 2011 was $9.35M, a 28.81% increase from fiscal 2010.
  • HI TECH PHARMACAL CO INC research and development expense for fiscal 2010 was $7.26M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2014-01-31$4.45M
10-Q · filed 2014-03-11
$9.54M
derived: sum of 2 quarters · filed 2014-03-11
$13.50M
10-Q · filed 2014-03-11
$17.05M
derived: sum of 4 quarters · filed 2014-03-11
2013-10-31$5.09M
10-Q · filed 2013-12-10
$9.05M
10-Q · filed 2013-12-10
$12.60M
derived: sum of 3 quarters · filed 2013-12-10
$18.57M
derived: sum of 4 quarters · filed 2013-12-10
2013-07-31$3.96M
10-Q · filed 2013-09-09
$7.51M
derived: sum of 2 quarters · filed 2013-09-09
$13.47M
derived: sum of 3 quarters · filed 2013-09-09
$16.82M
derived: sum of 4 quarters · filed 2013-12-10
2013-04-30$3.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-11
$9.52M
derived: sum of 2 quarters · filed 2013-07-11
$12.86M
derived: sum of 3 quarters · filed 2013-12-10
$17.33M
10-K · filed 2013-07-11
2013-01-31$5.96M
10-Q · filed 2014-03-11
$9.31M
derived: sum of 2 quarters · filed 2013-12-10
$13.78M
10-Q · filed 2014-03-11
$17.15M
derived: sum of 4 quarters · filed 2013-12-10
2012-10-31$3.34M
10-Q · filed 2013-12-10
$7.82M
10-Q · filed 2013-12-10
$11.19M
derived: sum of 3 quarters · filed 2013-12-10
$14.20M
derived: sum of 4 quarters · filed 2013-12-10
2012-07-31$4.47M
10-Q · filed 2013-09-09
$7.84M
derived: sum of 2 quarters · filed 2013-09-09
$10.86M
derived: sum of 3 quarters · filed 2013-09-09
$13.33M
derived: sum of 4 quarters · filed 2013-09-09
2012-04-30$3.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-11
$6.39M
derived: sum of 2 quarters · filed 2013-07-11
$8.86M
derived: sum of 3 quarters · filed 2013-07-11
$12.26M
10-K · filed 2013-07-11
2012-01-31$3.02M
10-Q · filed 2013-03-08
$5.49M
derived: sum of 2 quarters · filed 2013-03-08
$8.88M
10-Q · filed 2013-03-08
$11.21M
derived: sum of 4 quarters · filed 2013-07-11
2011-10-31$2.47M
10-Q · filed 2012-12-07
$5.87M
10-Q · filed 2012-12-07
$8.20M
derived: sum of 3 quarters · filed 2013-07-11
$10.87M
derived: sum of 4 quarters · filed 2013-07-11
2011-07-31$3.40M
10-Q · filed 2012-09-10
$5.73M
derived: sum of 2 quarters · filed 2013-07-11
$8.40M
derived: sum of 3 quarters · filed 2013-07-11
$10.80M
derived: sum of 4 quarters · filed 2013-07-11
2011-04-30$2.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-11
$5.00M
derived: sum of 2 quarters · filed 2013-07-11
$7.40M
derived: sum of 3 quarters · filed 2013-07-11
$9.35M
10-K · filed 2013-07-11
2011-01-31$2.67M
10-Q · filed 2012-03-09
$5.07M
derived: sum of 2 quarters · filed 2012-03-09
$7.02M
10-Q · filed 2012-03-09
2010-10-31$2.40M
10-Q · filed 2011-12-08
$4.35M
10-Q · filed 2011-12-08
2010-07-31$1.95M
10-Q · filed 2011-09-09
2010-04-30$7.26M
10-K · filed 2012-07-13